2025年7月22日

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group

We’re thrilled to announce a major milestone: XRP Healthcare M&A Holding Inc. has officially signed a Definitive Agreement with AAJ Capital 3 Corp. , and the esteemed ARC Group is serving as our exclusive financial

この記事は現在英語版でご利用いただけます。

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group

We’re thrilled to announce a major milestone: XRP Healthcare M&A Holding Inc. has officially signed a Definitive Agreement with AAJ Capital 3 Corp., and the esteemed ARC Group is serving as our exclusive financial advisor.

If you’re unfamiliar with capital markets, terms like RTO, CPC, TSXV, and Definitive Agreement might sound confusing. But don’t worry - we’ll break everything down in clear, jargon-free language so you understand what it means and why it matters.

Taking a Smarter Path to the Public Markets

When companies decide to go public, most people picture an IPO (Initial Public Offering) - a popular route where businesses sell shares on a stock exchange for the first time.

But we’re taking a faster, more flexible path: a Reverse Takeover (RTO).

What’s a Reverse Takeover (RTO), and How Does It Work?

Instead of launching an IPO from scratch, we’re merging with AAJ Capital 3 Corp., a Capital Pool Company (CPC) listed on the TSX Venture Exchange (TSXV) under the symbol AAAJ.P.

By following this route, XRP Healthcare M&A Holding Inc. becomes the new public entity. We’ll phase out the current listing (AAAJ.P) and replace it with our new name and ticker symbol on the TSXV.

The TSXV refers to this process as a Qualifying Transaction (QT) - a streamlined pathway designed to help high-growth companies like ours access the public markets more efficiently than with a traditional IPO.

What Does the “Definitive Agreement” Mean?

This agreement isn’t just a handshake - it’s a legally binding contract that defines every aspect of the merger, from share exchanges to legal obligations for closing the deal.

In short: both parties have agreed to move forward, pending regulatory approval.

Why ARC Group’s Involvement Matters

ARC Group brings elite financial expertise and a strong track record in international M&A and listings. They’re guiding us through jurisdictions including Canada, the UAE, and East Africa, ensuring we complete this transaction to the highest global standards. Their presence boosts both our credibility and strategic direction.

Why This Move Matters for XRP Healthcare

This isn’t just a financial step - it’s a strategic leap forward in our mission to transform healthcare access across Africa and other emerging markets.

We’ve already started acquiring pharmacies in Uganda, and our AI-powered, multilingual XRPH app is live - connecting users with healthcare insights, prescription support, and localized tools.

Going public empowers us to:

  • Gain greater visibility and trust

  • Attract institutional funding

  • Scale our AI and M&A model across regions

This means faster rollouts, broader reach, and deeper integration with the communities we serve.

What Comes Next?

With the Definitive Agreement signed, here’s what to expect:

  • Regulatory submission of the deal to the TSXV

  • Final approvals and compliance checks

  • Trading begins under the new XRP Healthcare M&A Holding Inc. name

  • Continued expansion of our AI platform and pharmacy acquisition roadmap

More Than a Business Move It’s a Movement

This journey isn’t just about listing shares. It’s about proving that a company with roots in London, operations in Dubai, and a vision for Africa.  Can meet the highest standards of international capital markets.

It’s about connecting innovation to impact, and capital to communities.

We’re honored to partner with ARC Group and AAJ Capital 3 Corp. in this endeavor and even more energized by what it means for the future of health access across the globe.

The path to public trading is now paved and this is just the beginning.


小売ネットワークへのアクセス

小売ネットワークへのアクセスは、United Networks of America(UNA)との契約を通じて提供されます。薬局ブランドの表示は、XRP Healthcare M&A Holding Inc.による所有、推奨、または直接的な提携を意味するものではありません。

戦略的ヘルステクノロジーパートナーシップ

技術パートナーシップは、協業またはプロジェクトベースの協力を示します。明示されていない限り、株式所有または推奨を意味するものではありません。

医薬品・供給パートナーシップ

医薬品および供給関係は、買収済みの運営事業体内に存在する商業上の取り決めを反映しています。表示は、標準的な商業供給契約を超える独占性または推奨を意味するものではありません。

アドバイザー

アドバイザーはXRP Healthcare M&A Holding Inc.に専門サービスを提供します。公表されていない限り、提携または所有権を意味するものではありません。

すべての第三者商標は、それぞれの所有者に帰属します。明示されていない限り、表示は推奨、所有、または提携を意味するものではありません。

XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group